U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07180745) titled 'Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease' on Sept. 11.
Brief Summary: The goal of this clinical trial is to assess the efficacy of Empagliflozin versus Statins as monotherapy and polytherapy in non-alcoholic fatty liver disease and non-alcoholic Steatohepatitis.
Does drug ABC Empagliflozin versus Statins as monotherapy and polytherapy improve the controlled attenuation parameter (CAP), the liver stiffness measurement (LSM), the proportion of patients with at least one point improvement or one-stage reduction in the histological scores with respect to hepatic steatosis, hepatocellular ballooning, lobular in...